-

Fujifilm Opens New Endoscopy Warehouse Facility in Fairfield, NJ, Expanding Service Operations and Supporting Continued Business Growth

New 18,000-square-foot facility strengthens operational capabilities while enabling expansion of Wayne, NJ-based service center and technician workforce

LEXINGTON, Mass.--(BUSINESS WIRE)--FUJIFILM Healthcare Americas Corporation, a leading provider of endoscopic imaging and endosurgical solutions, today announced the opening of its new 18,000-square-foot-warehouse facility in Fairfield, New Jersey. The new warehouse marks another strategic investment in the company’s continued growth and innovation of its endoscopy business. The Fairfield warehouse facility officially began operations in May 2026.

The new facility, celebrated during a ribbon-cutting ceremony today, is designed to support the division’s expanding operational and logistics needs while creating additional capacity at Fujifilm’s Wayne, N.J. location – home to the company’s endoscopy service operations.

By relocating warehouse operations to Fairfield, Fujifilm will be able to significantly upscale and expand its Wayne-based service center to meet increasing customer demand for responsive, high-quality service and support. As part of this expansion, the service center will grow approximately 1.5 times its original size, further enhancing its capacity to support healthcare providers across the country.

“The opening of our new Fairfield facility represents an important milestone for our endoscopy business and reflects Fujifilm’s ongoing investment in innovation, infrastructure, and customer support. From advancing service excellence to investing in our workforce and infrastructure, we are building for long-term growth,” said Tai Fujita, Senior Vice President, Endoscopy Division, FUJIFILM Healthcare Americas Corporation. “As healthcare providers continue to rely on advanced endoscopic technologies from Fujifilm to support patient care, we are committed to scaling our operations and service capabilities to continue to meet and exceed their evolving needs.”

The expanded service center operations in Wayne will further increase service efficiency, optimize turnaround times, and enhance technical support capabilities for Fujifilm customers nationwide. Fujifilm’s advanced imaging, cutting-edge endoscopes and devices empower gastroenterologists, advanced endoscopists, and their staff to take on today’s practice challenges with a comprehensive and expanding, next-generation portfolio of innovative endoscopic technologies. For more information on Fujifilm’s endoscopic imaging solutions, visit the website here.

About Fujifilm

FUJIFILM Healthcare Americas Corporation is a comprehensive healthcare company that has an extensive range of technology and expertise in the detection, diagnosis, and treatment of diseases. Fujifilm’s innovative portfolio includes solutions spanning diagnostic imaging, enterprise imaging, endoscopic imaging, surgical imaging, and in-vitro diagnostics. The Non-Destructive Testing group delivers radiography solutions to ensure high accuracy inspection of transportation infrastructure, and assets within aerospace, and oil and gas industries.

The company is headquartered in Lexington, Massachusetts. For more information on healthcare offerings, please visit healthcaresolutions-us.fujifilm.com, and for NDT portfolio, please visit https://www.fujifilm.com/us/en/business/industrial-materials/non-destructive-testing.

FUJIFILM Holdings Corporation, headquartered in Tokyo, leverages its depth of knowledge and proprietary core technologies to deliver innovative products and services across the globe through the four key business segments of healthcare, electronics, business innovation, and imaging with over 70,000 employees. Guided and united by our Group Purpose of “giving our world more smiles,” we address social challenges and create a positive impact on society through our products, services, and business operations. Under its medium-term management plan, VISION2030, which ends in FY2030, we aspire to continue our evolution into a company that creates value and smiles for various stakeholders as a collection of global leading businesses and achieve a global revenue of 4 trillion yen. For more information, please visit: https://holdings.fujifilm.com/en.

Contacts

Marissa Confredo
914-343-4761
Marissa.confredo@fujifilm.com

FUJIFILM Healthcare Americas Corporation


Release Versions

Contacts

Marissa Confredo
914-343-4761
Marissa.confredo@fujifilm.com

Social Media Profiles
More News From FUJIFILM Healthcare Americas Corporation

Capture What Shapes You - Fujifilm Introduces instax SQUARE 2™ instant camera

VALHALLA, N.Y.--(BUSINESS WIRE)--FUJIFILM North America Corporation, Imaging Division, today announced the launch of its instax SQUARE 2™ instant camera (hereafter SQUARE 2), the latest iteration in its iconic and popular instax™ SQUARE product lineup. SQUARE 2 brings a refreshed look and new features to fans of square instant photos. “Our instax™ SQUARE products have always brought the classic style and symmetry many instant photographers seek when making images,” said Bing Liem, division pres...

Fujifilm to Expand CMP Slurry Production Capacity in the United States

MESA, Ariz.--(BUSINESS WIRE)--FUJIFILM Corporation will expand its semiconductor materials business by enhancing production facilities for copper interconnect CMP (Chemical Mechanical Planarization) slurries*1 at the FUJIFILM Electronic Materials U.S.A., Inc. production site in Mesa, Arizona. Fujifilm will also establish new production facilities capable of multi-product manufacturing of CMP slurries for diversified semiconductor manufacturing processes, including advanced packaging application...

Fujifilm Launches Synapse Pathology v3.0, Advancing the Digital Pathology Experience With Expanded AI Capabilities

LEXINGTON, Mass.--(BUSINESS WIRE)--FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging solutions, today announced the launch of Synapse® Pathology v3.0. Featuring more than 50 new features and functions, Synapse Pathology v3.0 is designed to enhance the user experience while expanding the platform’s artificial intelligence (AI) capabilities to support the evolving needs of pathologists and laboratories. The new release will be showcased at Pathology...
Back to Newsroom